Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Interim Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income
Preferred stock
Accumulated deficit
Beginning Balance at Jun. 30, 2019 $ 1,968,000 $ 4,000 $ 57,543,000 $ 21,000 $ 4,978,000 $ (60,578,000)
Beginning Balance, shares at Jun. 30, 2019   3,839,000        
Issuance of shares and warrants - net ofissue costs 6,583,000 $ 5,000 6,578,000      
Issuance of shares and warrants - net of issue costs, shares   4,895,000        
Exercise of pre-funded warrants for cash 26,000 $ 2,000 24,000      
Exercise of pre-funded warrants for cash, shares   2,655,000        
Conversion of Series B preferred stockto common stock     174,000   (174,000)  
Conversion of Series B preferred stock to common stock, shares   6,000        
Shares issued for services 5,000 $ 4,843 5,000      
Shares issued for services, shares   6,925        
Stock option expense 51,000   51,000      
Series A Preferred cash dividend (2,000)         (2,000)
Series B Preferred stock dividend     2,000     (2,000)
Series B preferred stock dividend, shares   4,000        
Loss for the period (1,606,000)         (1,606,000)
Ending Balance at Sep. 30, 2019 7,025,000 $ 11,000 64,377,000 21,000 4,804,000 (62,188,000)
Ending Balance, shares at Sep. 30, 2019   11,406,000        
Beginning Balance at Jun. 30, 2019 1,968,000 $ 4,000 57,543,000 21,000 4,978,000 (60,578,000)
Beginning Balance, shares at Jun. 30, 2019   3,839,000        
Ending Balance at Jun. 30, 2020 263,000 $ 11,000 65,148,000 21,000 4,804,000 (69,721,000)
Ending Balance, shares at Jun. 30, 2020   11,458,000        
Adgero merger (note 3) 16,725,000 $ 12,000 16,713,000      
Adgero merger, shares   12,011,000        
Issuance of Series C Preferred stock 25,028,000       25,028,000  
Series C placement agent warrants     3,287,000   (3,287,000)  
Series C Preferred stock share issuance costs (3,386,000)       (3,386,000)  
Deemed dividend recognized on beneficial conversion features of Series C Preferred stock issuance     3,181,000     (3,181,000)
Exercise of warrants for cash 994,000 $ 1,000 993,000      
Exercise of warrants for cash, shares   993,000        
Warrants issued for services 45,000   45,000      
Shares issued for services   $ 0        
Shares issued for services, shares   0        
Stock option expense 405,000   405,000      
Series A Preferred cash dividend (2,000)         (2,000)
Series B Preferred stock dividend     5,000     (5,000)
Series B preferred stock dividend, shares   4,000        
Loss for the period (19,518,000)         (19,518,000)
Ending Balance at Sep. 30, 2020 $ 20,554,000 $ 24,000 $ 89,777,000 $ 21,000 $ 23,159,000 $ (92,427,000)
Ending Balance, shares at Sep. 30, 2020   24,466,000